Close

Iridex Corp (IRIX) Prelim. Q3 Revenue Misses Expectations

Go back to Iridex Corp (IRIX) Prelim. Q3 Revenue Misses Expectations

IRIDEX Announces Preliminary Revenues for 2016 Third Quarter

October 11, 2016 4:05 PM EDT

MOUNTAIN VIEW, Calif., Oct. 11, 2016 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $9.6 to $9.7 million for the third quarter ended October 1, 2016 compared to prior revenue guidance of $11.0 to $11.3 million.  While demand for the Company's new flagship Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations although the Company ended the third quarter with a record high in back orders.

G6 Platform Update - For the 2016 third quarter, the... More